Mechanisms of angiogenesis

被引:341
作者
Karamysheva, A. F. [1 ]
机构
[1] Russian Acad Med Sci, Inst Carcinogenesis, Blokhin Canc Res Ctr, Moscow 115478, Russia
关键词
angiogenesis; vascular endothelium growth factors (VEGF); neuropilins; PDGFB; angiopoietins;
D O I
10.1134/S0006297908070031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tissue activity of angiogenesis depends on the balance of many stimulating or inhibiting factors. The key signaling system that regulates proliferation and migration of endothelial cells forming the basis of any vessel are vascular endothelium growth factors (VEGF) and their receptors. The VEGF-dependent signaling system is necessary for formation of the embryonic vascular system. Neoangiogenesis during tumor growth is also associated with activation of this signaling system. The biological significance of the effect of such system on the cells depends on the content in tissue of various factors of the VEGF family and their receptors, while in the case of VEGFA it is defined by the ratio of different isoforms of this growth factor. A number of other signaling systems are also involved in regulation of the main steps of vessel formation. The signaling system D114/Notch regulates selection of endothelial cells for beginning of angiogenic expansion by endowing particular properties to endothelial cells leading in this process. An important step in vessel stabilization and maturation is vascular wall formation. Signaling system PDGFB/PDGFR beta as well as angiopoietins Ang1, Ang2, and their receptor Tie2 are involved in recruiting mural cells (pericytes and smooth muscle cells). Identification of key molecules involved in the regulation of angiogenesis may provide new possibilities for development of drugs suitable for inhibition of angiogenesis or its stimulation in various pathologies.
引用
收藏
页码:751 / 762
页数:12
相关论文
共 133 条
[1]   Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) [J].
Achen, MG ;
Jeltsch, M ;
Kukk, E ;
Mäkinen, T ;
Vitali, A ;
Wilks, AF ;
Alitalo, K ;
Stacker, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :548-553
[2]   Molecular mechanisms of lymphangiogenesis in health and disease [J].
Alitalo, K ;
Carmeliet, P .
CANCER CELL, 2002, 1 (03) :219-227
[3]   Endothelial/pericyte interactions [J].
Armulik, A ;
Abramsson, A ;
Betsholtz, C .
CIRCULATION RESEARCH, 2005, 97 (06) :512-523
[4]   Vascular endothelial growth factor d is dispensable for development of the lymphatic system [J].
Baldwin, ME ;
Halford, MA ;
Roufail, S ;
Williams, RA ;
Hibbs, ML ;
Grail, D ;
Kubo, H ;
Stacker, SA ;
Achen, MG .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (06) :2441-2449
[5]   Cellular abnormalities of blood vessels as targets in cancer [J].
Baluk, P ;
Hashizume, H ;
McDonald, DM .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (01) :102-111
[6]   Expression of Dll4 during mouse embryogenesis suggests multiple developmental roles [J].
Benedito, R ;
Duarte, A .
GENE EXPRESSION PATTERNS, 2005, 5 (06) :750-755
[7]   Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].
Benjamin, LE ;
Golijanin, D ;
Itin, A ;
Pode, D ;
Keshet, E .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165
[8]   The role of pericytes in blood-vessel formation and maintenance [J].
Bergers, G ;
Song, S .
NEURO-ONCOLOGY, 2005, 7 (04) :452-464
[9]   Insight into the physiological functions of PDGF through genetic studies in mice [J].
Betsholtz, C .
CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (04) :215-228
[10]   Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 [J].
Carmeliet, P ;
Ng, YS ;
Nuyens, D ;
Theilmeier, G ;
Brusselmans, K ;
Cornelissen, I ;
Ehler, E ;
Kakkar, VV ;
Stalmans, I ;
Mattot, V ;
Perriard, JC ;
Dewerchin, M ;
Flameng, W ;
Nagy, A ;
Lupu, F ;
Moons, L ;
Collen, D ;
D'Amore, PA ;
Shima, DT .
NATURE MEDICINE, 1999, 5 (05) :495-502